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Abstract
Introduction: Laser Doppler imaging (LDI) is a relatively new method for assessing the functional aspect of
superficial skin blood flow in systemic sclerosis (SSc) and Raynaud’s phenomenon. The present study investigated
the dynamic behavior of digital skin microvascular blood flow before and after cold stimulus (CS) in SSc patients
and in healthy controls by means of a comprehensive approach of the functional (LDI), morphological (nailfold
capillaroscopy (NFC)), and biochemical (fingertip lacticemy (FTL)) microcirculation components.
Methods: Forty-four SSc patients and 40 healthy controls were included. After acclimatization, all subjects
underwent NFC followed by LDI and FTL measurement. NFC was performed with a stereomicroscope under 10×
to 20× magnification in the 10 digits of the hands. Skin blood flow of the dorsum of four fingertips (excluding the
thumb) of the left hand was measured using LDI at baseline and for 30 minutes after CS. The mean finger blood
flow (FBF) of the four fingertips was expressed as arbitrary perfusion units. FTL was determined on the fourth left
finger before (pre-CS-FTL) and 10 minutes after CS.
Results: LDI showed significantly lower mean baseline FBF in SSc patients as compared with controls (296.9 ±
208.8 vs. 503.6 ± 146.4 perfusion units; P < 0.001) and also at all time points after CS (P < 0.001). There was a
significant decrease in mean FBF after CS as compared with baseline in SSc patients and in controls, followed by
recovery of the blood flow 27 minutes after CS in healthy controls, but not in SSc patients. FBF tended to be lower
in patients with digital scars and previous ulceration/amputation (P = 0.06). There was no correlation between
mean baseline FBF and NFC parameters. Interestingly, there was a negative correlation between FTL and FBF
measured by LDI in basal conditions and 10 minutes after CS in SSc patients.
Conclusions: LDI showed lower digital blood flow in SSc patients when compared with healthy controls and
correlated well with FTL both at baseline and after CS, allowing objective measurement of blood perfusion in SSc
patients. The lack of correlation between functional and morphological microvascular abnormalities, measured by
LDI and NFC, suggests they are complementary tools for evaluation of independent microangiopathy aspects in
SSc patients.
Introduction
Raynaud’s phenomenon (RP) is a relatively common
disorder characterized by episodic vasospasm of the
extremities with a triphasic color change (blanching,
cyanosis, and erythema) that usually occurs after
exposure to cold or emotional stress [1]. The disorder
can be idiopathic (primary RP) or secondary to systemic
or local conditions. Secondary RP is a frequent finding
in autoimmune rheumatic diseases, especially in
systemic sclerosis (SSc), and is often more severe than
primary RP [2]. In patients with SSc, structural abnorm-
alities of the vasculature involving the microcirculation
and the digital arteries, dysfunctional control of vascular
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tone, endothelial activation/lesion, and increased platelet
adhesion can be detected early [3,4]. These alterations
may result in progressive reduction of vessel lumen,
decreased blood flow, and a state of chronic hypoxia,
resulting in digital ulcers, digital pitting, and - in more
severe cases - gangrene of the extremities.
Several methods have been developed to assess micro-
vascular structural and functional abnormalities in
patients with SSc in order to study the mechanisms of
RP attacks, for differential diagnosis between primary
RP and secondary RP, and for measuring responsiveness
to treatment [5].
SSc peripheral microangiopathy can be easily recog-
nized by widefield nailfold capillaroscopy (NFC), a non-
invasive and safe method that is well established in the
investigation of patients with RP [6-8]. In healthy indivi-
duals, the NFC pattern is characterized by homogeneous
distribution of capillary loops similar in size and shape
[7,8]. Some variability can be observed but avascular
fields and megacapillaries are usually not detected [9].
Conversely, patients with SSc exhibit a typical NFC pat-
tern characterized by enlargement of capillary loops,
loss of capillaries, a variable degree of microhemorrhage,
disruption of the orderly appearance of the capillary
bed, and distortion of capillaries [8,10].
Lactate analysis is a common procedure in exercise
physiology laboratories to measure endurance perfor-
mance [11,12]. Determination of the lactic acid
concentration in blood obtained from fingertips
(fingertip lacticemy (FTL)) before and after a cold
stimulus (CS) has been previously developed by our
group for assessment of the biochemical component of
peripheral perfusion, and has been shown to provide
accurate information on the degree of local anerobiosis
in patients with RP and SSc [13,14]. In brief, a drop of
fingertip blood for lactic acid determination is obtained
in resting conditions (pre-CS-FTL) and after a CS
(post-CS-FTL). Our previous results showed higher
pre-CS-FTL and post-CS-FTL levels in SSc patients as
compared with normal controls and primary RP
patients, reflecting the high degree of tissue hypoxia
before and after a cold challenge in SSc patients
[13-15].
The relatively new technique of laser Doppler imaging
(LDI) allows an objective measurement of superficial
cutaneous microvascular blood flow, and constitutes a
promising approach in the assessment of the digital
microvascular vasoreactivity in response to CS in SSc
[16,17]. LDI has the advantages of being non-invasive
and of mapping tissue perfusion over a wide area of the
skin, thus providing more reproducible values [18]. The
principle of the LDI technique is based on the Doppler
effect, where changes in wavelength due to movement
between red blood cells and the observer (the scanner)
are used to determine the speed of blood flow [16].
Images are obtained by scanning a low-energy laser
beam across the tissue. Backscattered light from the tis-
sue, incident on a detector, is processed to provide a
signal that is directly proportional to the speed and con-
centration of moving red blood cells [16,19]. Although
promising, only few studies evaluated LDI associated
with vasoreactive tests in patients with RP and SSc
[16,17,20].
The aims of the present study were to evaluate the
dynamic behavior of digital skin microvascular blood
flow before and after CS using LDI in patients with RP
secondary to SSc compared with healthy controls, and
to correlate digital skin microvascular blood flow (mea-
sured by LDI) with structural microvascular abnormal-
ities (evaluated by NFC) and with biochemical
peripheral abnormalities (evaluated by the CS-FTL test)
in patients with SSc.
Materials and methods
Patients
Forty-four patients with RP secondary to SSc meeting
the American College of Rheumatology criteria [21] or
the LeRoy and Medger criteria for early SSc [22] were
consecutively selected from the Scleroderma Outpatient
Clinic at UNIFESP Medical School Hospital. Forty
healthy age-matched and gender-matched controls were
selected among students and hospital employees at the
same institution.
Exclusion criteria were the existence of active fingertip
ulceration, smoking, occupational exposure to a cold
environment and to vibratory agents, uncontrolled sys-
temic arterial hypertension or diabetes mellitus, and
clinical evidence of proximal arterial disease. Patients
stopped oral vasodilators or any other medication for
RP 3 days prior to the procedure. All individuals filled
out an informed consent form and underwent a thor-
ough rheumatologic examination. The study was
approved by the UNIFESP Ethics Committee (reference
number 1298/06).
Study design
After acclimatization for 60 minutes in a laboratory with
a constant temperature of 24 ± 1°C, all individuals
underwent the following procedures: NFC, measurement
of finger skin blood flow with the LDI, and measure-
ment of FTL. The LDI and FTL measurements were
performed before and after a CS.
Nailfold capillaroscopy
All NFC procedures were performed in a stereomicro-
scope (SZ40; Olympus, Melville, NY, USA) under 10×
to 20× magnification according to the protocol proposed
by Andrade and colleagues [7]. A transparent ruler is
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incorporated into the right eyepiece of the stereomicro-
scope, allowing reproducible measurements of capillary
width and of the number of capillary loops per milli-
meter. All 10 digits of the hands were examined except
when prevented by extremely poor visibility or
amputation.
The following parameters were analyzed: the number
of capillary loops per millimeter, the vascular deletion
score, the number of enlarged loops (over four times
the normal afferent, transition, and efferent limbs
width), and the number of giant capillary loops (10 or
more times the normal width of capillary limbs). The
vascular deletion score was assessed according to Lee
and colleagues’ method [23], in which a deletion area is
defined as the absence of two or more consecutive
loops. Each finger was rated from 0 to 3: 0 = no dele-
tion area; 1 = one or two discrete deletion areas; 2 =
more than two discrete deletion areas; 3 = extensive and
confluent deletion areas. For each patient, the NFC
parameters were calculated as the average obtained in
all analyzed digits. All NFCs were performed by the
same observer, blinded for the patient conditions.
Fingertip skin blood flow before and after cold stimulus
The blood flow of the dorsum of four fingertips (exclud-
ing the thumb) of the left hand was measured using a
laser Doppler imager (Moor LDI-VR; Moor Instruments,
Axminster, UK) before and after CS. All individuals
were in a sitting position with the left arm resting at
heart level. The laser Doppler imager uses a red helium-
neon laser operating at 633 nm with a penetration of
approximately 1 mm depth in the skin that is directed
onto the area of interest by a computer-controlled mir-
ror. All images were obtained at scan speeds of 4 ms/
pixel with a time of acquirement of 3 minutes and
15 seconds for each image. The distance between the
photodetector and the examined surface was 40 cm,
yielding an examined area of 168.5 cm2 (10.4 cm × 16.2
cm). The blood flow of the dorsum of the four fingertips
was determined by establishing four regions of interests
at each fingertip, defined as an area from the proximal
interphalangeal joint up to and including the nailbed.
The global mean finger blood flow (FBF) of the four fin-
gertips was derived (Moor LDI system software V5.2)
and averaged. Blood flow was displayed in arbitrary per-
fusion units (PU). The variability of FBF between the
four different fingers was also evaluated.
After baseline blood flow measurement, patients
underwent a CS (submersion of both hands in water at
15°C for 1 minute) (UNITEMP 116; Fanem, São Paulo,
SP, Brazil). Further laser Doppler scanning was per-
formed along a 30-minute interval after CS. Blood flow
measurements were made at 1 minute, 4 minutes and
15 seconds, 10 minutes and 45 seconds, 17 minutes
and 15 seconds, 20 minutes and 30 seconds, and at
27 minutes after CS.
Reproducibility of LDI was evaluated for four SSc
patients and four controls who underwent the procedure
on two different occasions 4 weeks apart. The basal
mean FBF was evaluated.
Cold stimulus fingertip lacticemy test
FTL was determined on the fourth left finger before
(pre-CS-FTL) and after (post-CS-FTL) CS. After the
baseline LDI measurement, a brisk puncture was per-
formed at the volar surface of the fingertip with an
automatic device (Softclix; Boehringer-Mannheim, Ger-
many) and the first blood drop was adsorbed onto a lac-
tate strip (Softclix, Boehringer-Mannheim, Germany).
The strip was processed immediately in a portable spec-
trophotometer (Accusport, Boehringer-Mannheim, Ger-
many). FTL was determined again 10 minutes after CS
(post-CS-FTL).
Statistical analysis
All results are expressed as the mean ± standard devia-
tion. Differences among groups were analyzed using
Student’s t test or the Mann-Whitney test. Longitudinal
comparison among successive time points was analyzed
by repeated-measures analysis of variance. Spearman’s
correlation coefficient was used to correlate FBF, FTL,
and NFC parameters. Reproducibility of LDI was evalu-
ated by Pearson’s correlation coefficient. P < 0.05 was
considered significant. Statistical analysis was performed
using SPSS statistical software (version 15 SPSSInc.,Chi-
cago,IL,USA).
Results
Forty-four SSc patients (three male, 41 female; 47.4 ±
10.5 years old) and 40 healthy controls (three male, 37
female; 46.9 ± 8.1 years old) were included with no sta-
tistical difference in age or gender between the two
groups (Table 1). Disease duration was 5.9 ± 5.5 years.
Seven patients (15.9%) had early SSc according to the
LeRoy and Medger criteria [22], 19 patients (43.1%) had
limited cutaneous SSc, and 18 patients (40.9%) had dif-
fuse cutaneous SSc. Twenty patients were using calcium
channel blockers, five patients were using captopril
(11.3%), and three patients were using losartan (6.8%).
Baseline FBF was significantly lower in SSc patients as
compared with controls (296.9 ± 208.8 vs. 503.6 ± 146.4
PU, respectively; P < 0.001). The same was true at all
time points after CS (P < 0.001) (Table 2).
There was a significant decrease in FBF after CS as
compared with baseline in SSc patients and in controls,
followed by recovering of FBF 27 minutes after CS in
healthy controls (P = 0.484) but not in SSc patients (P <
0.000) (Figure 1).
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There was no correlation between age or disease dura-
tion and baseline FBF (r = 0.011, P = 0.944 and r =
-0.237, P = 0.121, respectively). Interestingly, the base-
line FBF values tended to be lower in the group of 25
patients with digital scars and previous ulceration/ampu-
tation in comparison with the group of 19 patients with
absence of these abnormalities (218.35 ± 147.53 vs.
336.38 ± 223.5 PU, respectively; P = 0.06).
There was no difference in the FBF values in the 18
patients with diffuse cutaneous SSc as compared with
the 26 patients with limited cutaneous or early SSc at
baseline (286.5 ± 188.8 vs. 304.0 ± 225.0 PU, respec-
tively; P = 0.924) or after CS (data not shown).
The mean coefficient of variation of basal FBF
between the four fingers evaluated was 30% in SSc
patients (range, 3.4 to 54%), and 10.9% in controls
(range, 3.03 to 26.4%). Reproducibility of LDI showed an
intraclass correlation coefficient of 0.980 (P < 0.001),
with 95% limits of agreement of -49.86 to 27.74.
The CS-FTL test showed higher pre-CS-FTL and
post-CS-FTL values in patients with SSc than in normal
controls (pre-CS-FTL, 3.5 ± 2.7 vs. 2.4 ± 0.8 mg/dl,
respectively; P = 0.04; and post-CS-FTL, 2.7 ± 1.8 vs.
1.6 ± 0.7 mg/dl, respectively; P < 0.001). There was a
considerable decrease in FTL 10 minutes after CS in
normal controls (Percentage difference between post-
and pre-CS-FTL = -30.4 ± 20.3%) and only a slight
decrease in SSc patients (Percentage difference between
post- and pre-CS-FTL = -8.2 ± 43.5%) (P = 0.02). Inter-
estingly, there was a negative correlation between
FTL and FBF at baseline (r = -0.341, P = 0.023) and
10 minutes after CS (r = -0.456, P = 0.002) (Figure 2).
As expected, NFC showed a lower number of capillary
loops per millimeter in SSc patients than in controls
(P < 0.001), as well as a higher number of enlarged
capillary loops (P < 0.001), giant capillary loops (P <
0.001), and higher vascular deletion scores (P < 0.001)
(Table 3). There was no correlation between baseline
FBF and the NFC parameters in SSc patients (number
of capillary loops/mm, r = 0.091, P = 0.56; number of
enlarged capillary loops, r = -0.025, P = 0.87; number of
giant capillary loops, r = 0.046, P = 0.76; vascular dele-
tion score, r = -0.289, P = 0.22).
Discussion
The technique of LDI is currently considered a promis-
ing method for the study of microvascular involvement
in systemic rheumatic diseases [24]. The present study
originally evaluated the peripheral microcirculation
using LDI in association with two other methods that
address different aspects of SSc microangiopathy. The
present study therefore integrated parameters of micro-
vascular morphological abnormalities, assessed by NFC,
and the dynamic behavior of microvascular blood flow
before and after a vasoreactive stimulus, assessed by LDI
and FTL. SSc patients showed decreased digital perfu-
sion, as demonstrated by lower FBF and higher FTL at
baseline and after CS in comparison with healthy con-
trols. In addition, SSc patients exhibited a delay in digi-
tal blood flow recovery after CS, when compared with
healthy controls, as demonstrated by LDI. There was a
Table 1 Demographic, clinical and laboratory data of patients with systemic sclerosis and healthy controls
Systemic sclerosis patients
(n = 44)
Healthy controls
(n = 40)
P value
Age (years) 47.4 ± 10.5 46.9 ± 8.1 0.807
Gender (female/male) 41/3 37/3 0.904
Duration of Raynaud’s phenomenon (years) 8.0 ± 7.1 - -
Disease duration (years) 5.9 ± 5.5 - -
Presence of digital pitting scars, fingertip resorption, or digit amputation 25 (56.8%) - -
Antinuclear antibody 37 (84.1%) - -
Anti-Scl70 antibody 3 (6.8%) - -
Anti-centromere antibody 13 (29.5%) - -
Number of patients using calcium channel blockers (%) 20 (45%) - -
Table 2 Finger blood flow before and after cold stimulus
in controls and in systemic sclerosis patients
Finger blood flow (perfusion units)
Systemic sclerosis patients Healthy controls P value
Baseline FBF 296.9 ± 208.8 503.6 ± 146.4 <0.001
T1 FBF 113.5 ± 86.0 290.2 ± 131.0 <0.001
T4 FBF 155.1 ± 155.6 361.6 ± 177.0 <0.001
T10 FBF 221.3 ± 198.4 412.4 ± 172.1 <0.001
T17 FBF 218.3 ± 196.5 380.8 ± 147.2 <0.001
T20 FBF 224.3 ± 198.7 387.2 ± 142.9 <0.001
T27 FBF 209.9 ± 185.2 437.7 ± 171.8 <0.001
Data presented as mean ± standard deviation. Mean finger blood flow (FBF)
at baseline and after 15°C cold stimulus at different time points: T1, 1 minute;
T4, 4 minutes and 15 seconds; T10, 10 minutes and 45 seconds; T17, 17
minutes and 15 seconds; T20, 20 minutes and 30 seconds; and T27, 27
minutes after cold stimulus.
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moderate negative correlation between FBF and FTL at
baseline and after CS, indicating that SSc patients with a
more severe decrease in FBF, as measured by LDI, pre-
sented a higher degree of tissue hypoxia. SSc patients
presented also the typical NFC scleroderma pattern
characterized by enlarged and giant capillaries, and loss
of capillaries. There was no correlation, however,
between functional and morphological microvascular
abnormalities measured by LDI and NFC, suggesting
that these are complementary tools for evaluation of SSc
microangiopathy.
Interestingly, FBF tended to be lower in patients with
digital scars and previous ulcers or amputation - sug-
gesting that LDI could provide information on the
severity of peripheral vascular involvement in SSc. This
finding, however, deserves further investigation with a
larger sample of patients.
Several techniques have been developed to study
microcirculation function and for the measurement of
microvascular blood flow in patients with primary RP or
secondary RP - such as NFC, thermographic imaging,
plethysmography, single-point laser Doppler flowmetry,
and LDI [5,25]. The laser Doppler technique has proven
high sensitivity for measuring changes in digital skin
perfusion in response to a dynamic challenge [26].
Although single-point laser Doppler flowmetry has been
used in many studies to quantify blood flow in patients
with RP, the experience with LDI is still limited. LDI
allows the evaluation of larger areas of the microcircula-
tion as compared with other techniques, and provides a
direct measurement of blood flow in a given area of the
skin, as opposed to indirect methods such as
thermography.
The findings of lower baseline FBF and higher FTL in
SSc patients when compared with healthy controls are
supported by previous reports of severe narrowing of
capillaries and arterioles at the fingertips, devasculariza-
tion, and decreased blood flow in the microcirculation
of these patients [3,27], and are consistent with the con-
cept that the deranged arteriolar/capillary bed in this
disease ensues a chronic hypoxic regimen in the finger-
tips. Cold-induced changes have been used to provide
an evaluation of the degree of vasospasm in SSc patients
and to obtain information on the prognosis and man-
agement of these patients [17,20,28]. The absence of
FBF recovery until 30 minutes after CS observed in the
present report is consistent with several studies that
showed a higher reactivity after cold exposure and a
delayed blood flow recovery in SSc [20,29]. An array of
disturbances in blood flow dynamics observed in SSc
results in a slow and less effective capillary blood flow
after CS. The SSc microangiopathy involves dramatic
dysfunction in vascular regulatory mechanisms that pre-
sents initially with neural abnormalities, increased
release of endothelin-1, and reduced release of nitric
oxide and prostacyclin, and progresses to structural
derangement of the involved vessels [3,30]. As a result
of proliferation and fibrosis of the intimal layer, vessels
cannot compensate the critical impairment in blood
flow during RP attacks [31].
The present findings are also in agreement with pre-
vious studies using LDI for the evaluation of peripheral
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Figure 1 Mean finger blood flow at baseline and after cold stimulus. Mean finger blood flow (FBF) at baseline and after cold stimulus (CS)
in healthy controls and in systemic sclerosis (SSc) patients. P values correspond to the comparison between mean FBF at different time points
after CS in relation to the baseline FBF. PU, perfusion units.
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Figure 2 Correlation between fingertip lacticemy and mean finger blood flow. Correlation between fingertip lacticemy and mean finger
blood flow (FBF) (a) before and (b) 10 minutes after cold stimulus (CS) in systemic sclerosis (SSc) patients and healthy controls. PU, perfusion
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Table 3 Nailfold capillaroscopy parameters in systemic sclerosis patients and healthy controls
Nailfold capillaroscopy parameter
Number of capillary loops/
mm
Number of enlarged capillary
loops
Number of giant capillary
loops
Vascular deletion
score
Healthy
controls
10.1 ± 0.6 0.1 ± 0.2 0.0 ± 0.0 0.0 ± 0.0
SSc patients 6.7 ± 1.9 4.5 ± 2.7 0.3 ± 0.6 1.5 ± 0.9
P valuea <0.001 <0.001 <0.001 <0.001
aHealthy controls vs. systemic sclerosis (SSc) patients.
Correa et al. Arthritis Research & Therapy 2010, 12:R157
http://arthritis-research.com/content/12/4/R157
Page 6 of 8
blood flow in SSc patients. Picart and colleagues used
LDI before, during, and after CS (cold pad at 5°C for
8 minutes) in eight SSc patients, 10 patients with pri-
mary RP, and seven healthy controls [20]. As in our
study, SSc patients showed significantly lower perfusion
before, during, and after CS as compared with controls.
Murray and colleagues evaluated 16 patients with SSc,
14 patients with primary RP, and 16 healthy controls
using LDI before and after the same CS used in our
study [17]. The authors observed lower baseline perfu-
sion and a lower rewarming/reperfusion curve in
patients with SSc compared with healthy controls.
Finally, Seifalian and colleagues [32] and Rosato and
colleagues [33] showed lower baseline mean blood flow
in the hands of SSc patients compared with healthy con-
trols at room temperature, but no cold challenge was
applied.
An interesting point in the present study was the inte-
gration of functional parameters (LDI and FTL) and
morphological features of SSc microangiopathy. The
CS-FTL test previously developed by Pucinelli and col-
leagues in 2002 has demonstrated consistent abnormal-
ities before and after CS in SSc patients [13],
characterized by higher FTL values in comparison with
primary RP and healthy controls. The data reported
herein confirm our previous findings of higher FTL in
resting conditions and after CS in patients with SSc
[14,15]. These findings correlated nicely with the lower
baseline perfusion and longer recovery time observed
with the LDI method. This correlation is also consistent
with the concept of an association between decreased
blood flow and tissue hypoxia in patients with SSc.
The structural abnormalities of the microcirculation
were evaluated by NFC, the gold standard assessment
method for structural microvascular damage in sys-
temic rheumatic diseases [33]. Our findings confirmed
that NFC is a sensitive method for identification of
SSc microangiopathy [17]. The absence of correlation
between the microvascular morphological abnormal-
ities depicted by NFC and the digital blood flow evalu-
ated by LDI in SSc is not surprising since the two
methods evaluate different aspects of the microcircula-
tion. NFC evaluates morphological abnormalities speci-
fically on the capillaries of the nailfold bed, which are
relatively stable and usually do not change significantly
during short intervals of follow-up [34]. In the LDI
system, the type of vessels evaluated depends on the
penetration and absorption of the laser wavelength.
The red laser light (633 nm) used in the present study
has penetration depth of 0.5 to 1 mm in excised skin.
This light is more likely to be back-scattered to the
detector from larger, thermoregulatory-type microves-
sels, having passed through the capillaries without sig-
nificant interaction [16]. Additionally, since cutaneous
microcirculation is a dynamic system with functions
such as thermoregulation and metabolism, many envir-
onmental (temperature) and individual factors (hor-
mones, stress, vasoconstrictors medications) may
influence the cutaneous blood flow measured by LDI
[35]. Murray and colleagues showed only a weak nega-
tive correlation between the intercapillary distance
measured by NFC under 300× magnification and the
initial gradient in the first 2 minutes after CS mea-
sured by LDI [17]. They could not find any other cor-
relation between other nailfold capillary parameters
and LDI.
Conclusions
The finding of a decreased FBF at baseline and after CS
in patients with SSc indicates that LDI allows sensitive
and objective measurement of the digital skin blood
flow in patients with RP and SSc. Additionally, the
inverse correlation between FTL and FBF reveals the
deleterious consequences of decreased blood flow on tis-
sues, since high FTL reflects tissue hypoxia. Finally, the
lack of correlation between functional and morphologi-
cal microvascular abnormalities measured by LDI and
NFC suggests that it is appropriate to consider LDI and
NFC as complementary tools for evaluation of different
aspects of SSc microangiopathy. Further studies evaluat-
ing LDI as a technique for monitoring treatment
response and prospective studies with long follow-up
are warranted to investigate a possible role for LDI in
the evaluation of disease extension and severity of SSc.
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